Collapsing Focal Segmental Glomerulosclerosis Resulting from a Single Dose of Zoledronate
Bisphosphonates are commonly used for the treatment of osteoporosis, Paget's disease, multiple myeloma and hypercalcemia. Collapsing focal segmental glomerulosclerosis (FSGS) is known to occur uncommonly with exposure to bisphosphonates, specifically pamidronate and alendronate; it has rarely a...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
S. Karger AG
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241641/ |